mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |